| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 37607916
|
Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer
|
Nature Communications
|
10.1038/s41467-023-40715-x
|
2023
|
| 38347143
|
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
|
Nature Cancer
|
10.1038/s43018-024-00725-0
|
2024
|
| 38602320
|
The HLA-I landscape confers prognosis and antitumor immunity in breast cancer
|
Briefings in Bioinformatics
|
10.1093/bib/bbae151
|
2024
|
| 38605478
|
Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer
|
Cancer Biology & Medicine
|
10.20892/j.issn.2095-3941.2023.0492
|
2024
|
| 39244594
|
Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection
|
NPJ Precision Oncology
|
10.1038/s41698-024-00666-y
|
2024
|
| 39531335
|
MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor–positive HER2-negative breast cancer
|
The Journal of Clinical Investigation
|
10.1172/JCI183656
|
2024
|
| 39848244
|
Multimodal integration using a machine learning approach facilitates risk stratification in HR+/HER2− breast cancer
|
Cell Reports Medicine
|
10.1016/j.xcrm.2024.101924
|
2025
|
| 40612672
|
Multi-cohort validation of a lipid metabolism and ferroptosis-associated index for prognosis and immunotherapy response prediction in hormone receptor-positive breast cancer
|
International Journal of Biological Sciences
|
10.7150/ijbs.113213
|
2025
|
| 41387728
|
Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment response
|
NPJ Breast Cancer
|
10.1038/s41523-025-00881-1
|
2025
|
|
